These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15197945)

  • 21. Continuous erythropoietin receptor activator (Mircera) for renal anemia.
    McGahan L
    Issues Emerg Health Technol; 2008 Feb; (113):1-6. PubMed ID: 18354858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients.
    Besarab A; Reyes CM; Hornberger J
    Am J Kidney Dis; 2002 Sep; 40(3):439-46. PubMed ID: 12200793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G; Lubas A; Sienkiewicz M; Janusz E; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Erythropoietin treatment of dialysis patients].
    Stenver DI; Nielsen B
    Ugeskr Laeger; 1994 Apr; 156(17):2589-91. PubMed ID: 8016967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anemia syndrome in patients with chronic renal insufficiency on peritoneal dialysis treated with recombinant erythropoietin].
    Romanova LA; Lugovskaia SA; Khareb F; Shumov EV; Shmarov DA
    Urologiia; 2002; (5):26-30. PubMed ID: 12402772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaemia therapies.
    Melnikova I
    Nat Rev Drug Discov; 2006 Aug; 5(8):627-8. PubMed ID: 16918019
    [No Abstract]   [Full Text] [Related]  

  • 31. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients.
    Ioka T; Tsuruoka S; Ito C; Iwaguro H; Asahara T; Fujimura A; Kusano E
    Clin Pharmacol Ther; 2009 Aug; 86(2):154-9. PubMed ID: 19458615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anemia in renal insufficiency.
    Santoro A
    Rev Clin Exp Hematol; 2002; Suppl 1():12-20. PubMed ID: 12735211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M; Boguszewska-Baczkowska A; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothyroidism and resistance to human recombinant erythropoietin.
    Touam M; Guéry B; Goupy C; Menoyo V; Drüeke T
    Nephrol Dial Transplant; 2004 Apr; 19(4):1020-1. PubMed ID: 15031379
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythropoietin treatment in renal anemia. How high should the target hematocrit be?
    Minetti L
    J Nephrol; 1997; 10(3):117-9. PubMed ID: 9238619
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythropoietin dose and angiotensin-converting enzyme inhibitors.
    Grzegorzewska AE
    Perit Dial Int; 2007; 27(1):102-3. PubMed ID: 17179526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.